16.53

1.29% +0.21

PetIQ Inc (PETQ)

Overview News Price History Option Chain Discussions Forecast

PetIQ Inc stock is currently priced at $16.53, with a 24-hour trading volume of 122.97K. It has seen a +1.29% increased in the last 24 hours and a -7.08% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $16.26 pivot point. If it approaches the $16.54 resistance level, significant changes may occur.

Previous Close:

$16.32

Open:

$16.29

24h Volume:

122.97K

Market Cap:

$487.36M

Revenue:

$1.10B

Net Income/Loss:

$2.13M

P/E Ratio:

-12.91

EPS:

-1.28

Net Cash Flow:

$52.74M

1W Performance:

+1.54%

1M Performance:

-7.08%

6M Performance:

-11.18%

1Y Performance:

+43.49%

1D Range:

$16.18

$16.56

52W Range:

$11.26

$22.98

PetIQ Inc Stock (PETQ) Company Profile

Name

PetIQ Inc

Sector

Healthcare (1191)

Industry

Drug Manufacturers - Specialty & Generic (4)

Phone

208-939-8900

Address

923 South Bridgeway Place, Eagle, ID

Employee

225

Twitter

@PetIQBrand

Next Earnings Date

2024-05-08

Latest SEC Filings

PETQ's Discussions on Twitter

PetIQ Inc Stock (PETQ) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-19-23	Initiated	Jefferies	Buy
Sep-06-23	Initiated	Lake Street	Buy
May-13-22	Downgrade	Oppenheimer	Outperform → Perform
Nov-30-21	Initiated	The Benchmark Company	Buy
Oct-16-20	Resumed	Jefferies	Buy
May-23-19	Initiated	Guggenheim	Buy
Sep-28-18	Initiated	CL King	Buy

View All

PetIQ Inc Stock (PETQ) Latest News

Is PetIQ (PETQ) a Great Value Stock Right Now?

Zacks Investment Research

PetIQ, Inc. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024

GlobeNewswire Inc.

Wall Street Analysts Think PetIQ (PETQ) Could Surge 76.18%: Read This Before Placing a Bet

Zacks Investment Research

PetIQ Inc Stock (PETQ) Financials Data

PetIQ Inc (PETQ) Revenue 2024

PETQ reported a revenue (TTM) of $1.10 billion for the quarter ending December 31, 2023, a +19.58% rise year-over-year.

PetIQ Inc (PETQ) Net Income 2024

PETQ net income (TTM) was $2.13 million for the quarter ending December 31, 2023, a +104.42% increase year-over-year.

PetIQ Inc (PETQ) Cash Flow 2024

PETQ recorded a free cash flow (TTM) of $52.74 million for the quarter ending December 31, 2023, a +46.30% increase year-over-year.

PetIQ Inc (PETQ) Earnings per Share 2024

PETQ earnings per share (TTM) was $0.06 for the quarter ending December 31, 2023, a +103.64% growth year-over-year.

PetIQ, Inc. operates as a pet health and wellness company. It provides veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats. The company offers pet prescription medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars; and health and wellness products consisting of specialty treats and other pet products, which include dental treats and nutritional supplements. The company provides its products primarily under the VetIQ, PetAction Plus, Advecta, PetLock Plus, and TruProfen brands. It sells its products through approximately 60,000 points of distribution across retail and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.